AzTrials
AzTrials

Research institution

The Children's Hospital of Zhejiang University School of Medicine Clinical Trials

Studies where The Children's Hospital of Zhejiang University School of Medicine is the lead sponsor: what is enrolling now, by phase, condition and country.

69 registered studies

In numbers

Open to volunteers
48
Active
52
With results posted
0
All registered
69

Open to volunteers: recruiting, not yet recruiting or enrolling by invitation. Active adds studies under way that have stopped recruiting.

Open to volunteers

All 48
  • Very Preterm Infant, Necrotizing Enterocolitis (NEC)

    Effects of Enteral Feeding Regimens on NEC, Mortality, and Neurodevelopment in Very Preterm Infants

    • Recruiting
    • Age: 1 day to 90 days

    The goal of this clinical trial is to evaluate whether supplementing with pasteurized donor human milk (pHDM) or preterm formula (PTF) when own mother's milk (OMM) is insufficient can improve outcomes in very preterm infants born…

    Trial name
    NCT07045844
    Testing
    Pasteurized Donor Milk for Insufficient Breastfeeding, Preterm Formula for Insufficient Breastfeeding, Routine fortification
    Where
    24 sites in China
    Volunteers
    2,324 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? NCT07045844
  • Acute Lymphoblastic Leukemia, Pediatric

    Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival

    • Recruiting
    • Age: 1 month to 18 years
    • Observational study

    The study aims to conduct a real-world investigation of children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in China, assessing their diagnosis, treatment status, survival outcomes, and…

    Trial name
    RWD-Ph+ ALL (NCT07813208)
    Where
    China
    Volunteers
    500 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? RWD-Ph+ ALL
  • Autoimmune Diseases, SLE - Systemic Lupus Erythematosus

    RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases

    • Not yet recruiting
    • Age: 5 to 20 years
    • Early Phase 1
    • Injection or infusion

    This is a single-arm, open-label, phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05, a universal CD19/BCMA dual-targeting chimeric antigen receptor T-cell…

    Conditions
    Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory Myopathies
    Trial name
    NCT07674147
    Testing
    RD06-05 CART Cell Infusion
    Where
    2 sites in China
    Volunteers
    30 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? NCT07674147
  • Cancer, Glioma

    Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors

    • Recruiting
    • Age: 8 to 18 years
    • Observational study

    Advances in medical care have significantly improved survival among children with cancer. In China, the 5-year survival rate has reached 71.9%.

    Conditions
    Cancer, Glioma, Leukemia (Both ALL and AML)
    Trial name
    SC-Het-GM-CCS (NCT07450872)
    Where
    China
    Volunteers
    600 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
  • Diabetes (Insulin-requiring, Type 1 or Type 2), Skin Abnormalities

    Study on Influencing Factors of Skin Complications Related to Insulin Injection in Children With Type 1 Diabetes Mellitus

    • Not yet recruiting
    • Age: All ages
    • Observational study

    This study was a cross-sectional, observational design without involving random grouping or intervention. From July 2026 to June 2027, 199 children with type 1 diabetes who had received insulin treatment for at least 6 months and…

    Trial name
    NCT07615803
    Volunteers
    199 people, healthy volunteers welcome
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? NCT07615803
  • Vitiligo

    Efficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo

    • Not yet recruiting
    • Age: 2 to 11 years
    • Phase 3

    The goal of this clinical trial is to evaluate the efficacy and safety of Ruxolitinib Phosphate Cream in treating non-segmental vitiligo in children aged 2 to 11 years under real-world conditions.

    Trial name
    NCT07595939
    Testing
    Ruxolitinib 1.5% Cream BID
    Where
    China
    Volunteers
    20 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? NCT07595939
  • Congenital Heart Disease, Physical Inactivity

    Exergame-Based Physical Activity Promotion for Children and Adolescents With Congenital Heart Disease

    • Not yet recruiting
    • Age: 8 to 18 years
    • Lifestyle or therapy programme

    The goal of this clinical trial is to learn whether a Nintendo Switch-based exergame physical activity program can help children and adolescents with congenital heart disease increase their physical activity.

    Trial name
    ExPACE-CHD (NCT07593118)
    Testing
    Nintendo Switch-Based Exergame Physical Activity Promotion Intervention
    Where
    China
    Volunteers
    13 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? ExPACE-CHD
  • Autoimmune Diseases, Systemic Lupus Erthematosus (SLE)

    CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease

    • Recruiting
    • Age: 3 years and older
    • Early Phase 1

    This is an exploratory, open-label, single-arm clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of QT-219CX.

    Conditions
    Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy (IgAN)
    Trial name
    NCT07586267
    Testing
    QT-219CX
    Where
    China
    Volunteers
    15 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
    Can I take part? NCT07586267
  • Congenital Heart Disease (CHD), Congenital Heart Disease in Children

    Adaptive Digital Exercise Rehabilitation for Children After CHD Surgery

    • Not yet recruiting
    • Age: 6 to 12 years
    • Lifestyle or therapy programme

    The goal of this clinical trial is to evaluate whether a Just-in-Time Adaptive Intervention (JITAI)-based digital exercise rehabilitation program can improve postoperative recovery in children after congenital heart disease (CHD)…

    Trial name
    NCT07574463
    Testing
    JITAI-Based Digital Exercise Rehabilitation Program, Standard Exercise Rehabilitation Program
    Where
    China
    Volunteers
    130 people
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine
  • HPV, Vaccination Hesitancy

    A Bio-Psycho-Social Medical Model-Based Study on Adolescent Female HPV Vaccination Behavior and Comprehensive Intervention

    • Not yet recruiting
    • Age: 9 to 17 years
    • Lifestyle or therapy programme

    Based on the biopsychosocial (BPS) medical model, this study focuses on HPV vaccination behavior among adolescent females. It aims to explore the influence of multidimensional factors-including biological characteristics…

    Conditions
    HPV, Vaccination Hesitancy, Biopsychosocial Model
    Trial name
    NCT07562984
    Testing
    the BPS-based comprehensive intervention
    Volunteers
    300 people, healthy volunteers welcome
    Sponsor
    The Children's Hospital of Zhejiang University School of Medicine

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in